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Chronic inflammation has been associated with insulin resistance and type 2 diabetes
(T2D) in humans. Postmortem hepatic and splenic tissue from a 46-year-old geriatric male
bottlenose dolphin (Tursiops truncatus) with insulin resistance (chronic hyperinsulinemia
with hyperglycemia), chronic inflammation (white blood cell count greater than 12,000
cells/µL), and mild fatty liver disease was evaluated for elevated pro-inflammatory media-
tors. Cytokine mRNA expression in postmortem hepatic and splenic tissue, as determined
by real-time PCR, included an array of cytokines: TGF-β, TNF-α, IFN-γ, IL-2, IL-4, IL-10, IL-
12p40, IL-13, and IL-18. Values from this dolphin were compared to a younger reference
dolphin with no known chronic metabolic perturbations or inflammation. Levels of TGF-β,
TNF-α, and IL-4 were higher in the case dolphin’s liver compared to that of the reference
dolphin. In the case dolphin’s spleen, IL-10 and IFN-γ mRNA was upregulated while IL-4
was less than the reference dolphin. IL-18 and IL-13 were upregulated in both tissues. Flu-
orescent immunohistochemistry (IHC) utilized the following antibodies: anti-porcine IL-6,
anti-bovine IFN-γ, IL-4, and IL-10, anti-human TGF-β, anti-ovine IL-1β, and anti-dolphin IL-8.
Fluorescent IHC in spleen from the case dolphin revealed staining of IL-4, IL-6, IL-8, andTGF-
β throughout the tissue. IL-10 and IFN-γ were seen to predominate in areas surrounding
the follicles of splenic tissue. This is the first characterization of cytokine levels in dolphin
hepatic and splenic tissue. While there are limitations to a case study, this report of inflam-
matory biomarkers in tissues of a dolphin with insulin resistance and fatty liver disease are
similar to those observed in human patients.
Keywords:Tursiops truncatus, hyperinsulinemia, diabetes, inflammation, cytokines, real-time PCR, immunohisto-
chemistry
INTRODUCTION
Chronic inflammation is associated with, and can be a driver of,
insulin resistance and type 2 diabetes (T2D) in humans (1–6). Pri-
mary cytokines involved in insulin resistance-associated inflam-
mation are tumor necrosis factor alpha (TNF-α) and interleukin-6
(IL-6) (7–10). Additional cytokines associated with metabolic
perturbations include IL-1β, IL-8, IL-10, transforming growth
factor-beta (TGF-β), and nerve growth factor (11). Neutraliza-
tion of TNF-α in obese-diabetic rodents lead to elevated insulin-
stimulated peripheral glucose uptake and an overall increase in
insulin sensitivity in adipocytes as compared to the controls (12–
14). TNF-α signaling induces production of suppressor of cytokine
signaling (SOCS), I kappa B kinase beta (Ikkβ), C-jun N-terminal
kinase 1 (JNK1), and nitric oxide, which block insulin receptor
substrate signal transduction of the insulin receptor (15). While
obesity is a commonly researched underlying factor related to
chronic inflammation and insulin resistance in humans, inflam-
mation can also be an independent predictor of insulin resistance
in non-obese people (16).
Bottlenose dolphins (Tursiops truncatus) are emerging as a
model for T2D (17). After dolphins consume a high-protein
diet, plasma glucose levels rise for up to 5 h, and oral admin-
istration of dextrose causes a sustained period (up to 10 h) of
hyperglycemia. Further, dolphins are susceptible to diseases and
conditions associated with insulin resistance, including chronic
inflammation (18). Dolphin-specific cytokine assays were devel-
oped to evaluate cytokine activity in this species. The current
case study applied real-time polymerase chain reaction (PCR)
assays and fluorescent immunohistochemical staining in post-
mortem hepatic and splenic tissue from a geriatric, 46-year-old
dolphin with a history of insulin resistance (chronic hyperinsu-
linemia with hyperglycemia), chronic inflammation, and fatty liver
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disease. In humans, hyperinsulinemia and chronic inflammation
have been correlated with insulin resistance (1, 19). Specifically,
middle-aged males and females with metabolic syndrome have an
increased risk for T2D (20). This dolphin died from anaphylac-
tic shock, and related immunologic changes were also expected.
Immune values from the case dolphin were compared to those
from a reference dolphin with no metabolic perturbations. The
presence and quantity of cytokines in the spleen and liver were
determined using real-time PCR assays and fluorescent immuno-
histochemistry (IHC) for mRNA and protein, respectively. This
study represents the first evaluation of cytokines in bottlenose
dolphin hepatic and splenic tissue.
MATERIALS AND METHODS
SUBJECTS AND SAMPLE COLLECTION
Fresh postmortem tissue from liver and spleen were collected
opportunistically from two bottlenose dolphins in the same man-
aged population. Spleen was selected as a representative secondary
lymphoid tissue. Samples were snap frozen and stored frozen for
later experiments. The case dolphin was a geriatric 46-year-old
male with insulin resistance (chronic glucose>122 mg/dL and 2 h
postprandial insulin >20µIU/mL) that died unexpectedly from
anaphylactic shock. The reference dolphin was a juvenile male with
no evidence of liver disease that died acutely from non-infectious
and non-toxic causes. This dolphin had no history of elevated liver
enzymes or iron, and no significant findings in hepatic, splenic, or
pancreatic tissue upon histologic examination. Historical medical
records, including blood data and histologic reports, from the case
animal were also reviewed.
TOTAL RNA EXTRACTION AND cDNA SYNTHESIS
Tissues were removed from RNA later Solution (Qiagen) and
minced before adding TRIzol Reagent (Invitrogen). Phase separa-
tion was accomplished by addition of chloroform and the samples
centrifuged at 3400 rpm for 1 h at 4°C. The supernatant was col-
lected and isopropyl alcohol added to precipitate the RNA. After
centrifugation at 3400 rpm for 30 min at 4°C, the supernatant was
discarded and the RNA pellet was washed with 75% ethanol and
centrifuged. The supernatant was discarded and the RNA pel-
let allowed to dry before being dissolved in RNase-free water.
DNase digestion was accomplished using the Ambion TURBO
DNA-free kit. RNaseOUT (Invitrogen) was added to each sample.
First-strand cDNA synthesis was successful with 300 ng of RNA
transcribed using Random Primers and dNTP Mix followed by
5× First-Strand Buffer, 0.1 M DTT, and Superscript III Reverse
Transcriptase (Invitrogen).
REAL-TIME PCR ASSAY
Polymerase chain reaction primers were developed specifically for
SYBR Green quantification. All sequences were based on previ-
ously published information (21). Briefly, SYBR Green Master-
mix (Invitrogen) was added to 10µM of both the forward and
reverse primer (Integrated DNA Technologies), dH2O, and cDNA
template. The amplification conditions were: 95°C for 10 min,
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min, and
a final dissociation step. Plates were run on an Applied Biosys-
tems 7300 Real-Time PCR System. Relative gene expression was
determined using the 2−∆∆Ct method (22). S-9 was used as the
reference gene.
FLUORESCENT IHC
Snap-frozen sections of dolphin spleen in optimal cutting tem-
perature (OCT) compound (Tissue Tek) were cut, 5µm thick,
with a cryostat and placed on clean poly-l-lysine coated glass
slides. The tissue was immediately fixed with an equal ratio of ace-
tone to methanol for 10 min. A liquid-wax boundary was drawn
around the tissue with a Super PAP Pen (Invitrogen) to protect
against reagent loss. Tissues were blocked with Background Buster
(Accurate Chemical and Scientific Corporation) and avidin, if
applicable, from an Avidin/Biotin Blocking Kit (Vector) for 45 min.
Following a wash with 1× Tris buffer, primary cytokine anti-
bodies were added at varying concentrations and incubated at
room temperature for 1 h, unless noted (Table 1). After washing
with 1× Tris buffer, appropriate secondary antibodies conjugated
to either Alexa Fluor 488 or Alexa Fluor 594 (Invitrogen) were
then incubated at a concentration of 5µg/mL for another hour
at room temperature in the dark. Ki67 antibody (Thermo Sci-
entific) was used at a 1:500 dilution and incubated for 1 h with
both primary and secondary antibody as described above. In some
cases, CD2 was costained as described previously at a concentra-
tion of 1:100. The slides were washed a final time with 1× Tris
buffer and allowed to dry. Sections were mounted using VEC-
TASHIELD HardSet Mounting Medium with DAPI (Vector) and
coverslipped. The mounting medium was left to cure overnight
until visualization the following day using a Zeiss Axio Scope.A1
microscope.
Table 1 | Primary antibodies used for fluorescent IHC.
Cytokine specificity Type of antibody Species Dilution Source
CD2 mAb (IgG1) Dolphin 1:100 UC Davis UC-F21.C
Ki67 pAb Multiple species 1:500 Thermo Scientific PA5-19462
IL-1β pAb Ovine 1:50 overnight Serotec AHP 423
IL-4 mAb (IgG2a) Bovine 1:25 Serotec MCA2371
IL-6 pAb Porcine 1:50 Thermo Scientific PP690
IL-8 pAb Dolphin 1:200 Kingfisher Biotech, Inc. PB0377P
IL-10 mAb (IgG2b) Bovine 1:50 overnight Serotec MCA2110
IFN-γ: biotin mAb (IgG1) Bovine 1:50 Serotec MCA1783B
TGF-β mAb (IgG1) Human 1:50 overnight Serotec MCA797
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RESULTS
DOLPHIN CLINICAL RESULTS
The case dolphin had a clinical history of chronic, high liver
enzymes (alanine transaminase >42 U/L, aspartate transaminase
>263 U/L, and gamma-glutamyl transpeptidase >44 U/L) and
serum iron that began at the age of 25 years and peaked at 42 years
[Figure 1A; (23)]. A liver biopsy at that time demonstrated that
this dolphin had diffuse, moderate hemosiderosis, mild multifo-
cal vacuolar degeneration, mild amounts of granular intracellular
iron in hepatocytes, and moderate amounts of intracellular iron
visualized via staining in the Kupffer cells. The case dolphin was
diagnosed with hemochromatosis (iron overload) and successfully
treated with a 20-week course of phlebotomy (23). The dolphin
was 43 years old when treatment was completed; all liver enzymes
and serum iron values had returned to normal levels for this
dolphin population (24).
The case dolphin had repeatedly high 2-h postprandial insulin
levels (mean= 31± 11µIU/mL and median= 28, range 17–
52µIU/mL, based upon 16 sampling dates), chronically high glu-
cose (>122 mg/dL), white blood cell counts (>12,000 cells/µL),
and high and rising cholesterol (>286 mg/dL) based upon refer-
ence values for this dolphin population (25). Both high glucose
and cholesterol remained present after treatment for hemochro-
matosis (Figures 1B,C). When the dolphin died at 46 years old, he
had no evidence of hepatic iron deposition, supporting that iron
overload in the liver had been successfully treated. Postmortem
liver had mild, subacute periportal lymphoplasmacytic inflam-
mation; cholestasis; and mild diffuse, hepatocellular fatty change
confirmed to be lipid type with oil red O staining (26). Upon histo-
logic evaluation, there were no significant findings in the pancreas
or spleen.
CYTOKINE GENE EXPRESSION LEVELS IN A DOLPHIN WITH
HYPERINSULINEMIA AS COMPARED TO A REFERENCE
Tissue-specific differences in pro- and anti-inflammatory cytokine
mRNA expression between the case and reference dolphin were
observed by real-time PCR in the liver (Figure 2) and spleen
(Figure 3). Levels of TGF-β and TNF-α in the liver were upreg-
ulated, but were similar to the reference dolphin in the spleen.
IL-18 and IL-13 were upregulated in both tissues. On the other
FIGURE 1 |Time series of blood value changes in the case bottlenose dolphin (Tursiops truncatus) with treated hepatic iron overload and chronic,
postprandial hyperinsulinemia, and mild fatty liver disease: (A) alanine transaminase, (B) glucose, (C) cholesterol, and (D) white blood cell count.
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FIGURE 2 | Cytokine message levels in the liver of a dolphin with
hyperinsulinemia. In the liver, each target gene was determined by
real-time PCR and normalized first to S-9, a ribosomal control gene to give a
∆Ct. The ∆∆Ct was determined for the dolphin with hyperinsulinemia by
normalizing to a healthy control. The ∆∆Ct were transformed (2−∆∆Ct) to
show the expression of each cytokine message as a fold change. A fold
change of 2 or more was considered to be upregulated in the dolphin with
hyperinsulinemia.
FIGURE 3 | Cytokine message levels in the spleen of a dolphin with
hyperinsulinemia. In the spleen, each target gene was determined by
real-time PCR and normalized first to S-9, a ribosomal control gene to give a
∆Ct. The ∆∆Ct was determined for the dolphin with hyperinsulinemia by
normalizing to a healthy control. The ∆∆Ct were transformed (2∼∆∆Ct) to
show the expression of each cytokine message as a fold change. A fold
change of 2 or more was considered to be upregulated in the dolphin with
hyperinsulinemia.
hand, IL-10 mRNA expression was lower than expression in the
reference liver while IL-4 was upregulated; the opposite was true in
the spleen. IL-12p40 levels were lower in the liver and similar in the
spleen compared to the reference dolphin. IL-2 was not increased
in the spleen and not detectable in the liver. IFN-γ was lower than
the reference dolphin in the liver, but upregulated in the spleen.
CYTOKINE EXPRESSION IN THE SPLEEN AS DETECTED BY
FLUORESCENT IHC
We next examined the localization of cytokines in splenic tissue
samples from the case dolphin. Fluorescent IHC staining using
an antibody to Ki67, which recognizes a nuclear cell proliferation
antigen, in the dolphin with hyperinsulinemia showed evidence of
multiple germinal centers at various stages of development in the
splenic tissue examined, with one representative example shown
in Figure 4. Areas of CD2 staining, the T-cell zone, surrounded
the germinal centers. Staining of IL-6 and IL-8 was seen in the
splenic red pulp, as well as in the germinal centers and T-cell zones
(Figure 5), while TGF-β was evidently localized to the red pulp
of the spleen (Figure 6). IL-1β and IL-10 staining were seen in
the T-cell zone (Figure 7). Two different staining patterns were
observed for IL-4; minimal staining was found within the B-cell
follicle, while more prominent punctate staining was localized to
the red pulp (Figure 7). IFN-γ staining was detected in the T-cell
zone and red pulp of the spleen (Figure 8; and data not shown).
DISCUSSION
Compared to a reference bottlenose dolphin without metabolic
perturbations, the current study identified activated cytokine gene
expression, including TGF-β, TNF-α, IFN-γ, IL-18, IL-13, IL-10,
and IL-4 in the liver or spleen of a geriatric bottlenose dolphin with
hyperinsulinemia. The case dolphin has been previously identified
as having insulin resistance (chronic postprandial hyperinsuline-
mia and hyperglycemia) and mild fatty liver disease (17, 23, 26).
High white blood cell counts in humans can predict development
of T2D, and the clinical profile of the case dolphin, including high
white blood cell counts, supports that it had chronic inflammation
associated with T2D (27). The source of chronic inflammation was
not evident upon histological examination.
This study shows that a dolphin with hyperinsulinemia and
metabolic syndrome exhibited similar altered cytokine expression
as has been shown in humans and mice with hyperinsulinemia
and T2D. Pro-inflammatory cytokines are strong contributors to
increased insulin resistance, specifically TNF-α (8, 11, 28, 29).
TNF-α interferes with the signaling of the insulin receptor (14).
As expected, this dolphin with metabolic syndrome and hyperin-
sulinemia displayed levels of TNF-α in the liver that were higher
than the reference. IL-6 has also been linked to a hyperinsulinemic
state (8, 11). Fluorescent IHC in the spleen of the dolphin with
hyperinsulinemia did reveal abundant staining for IL-6. In the
hyperinsulinemic dolphin, IL-18 mRNA was upregulated in both
the spleen and liver. This is consistent with reports in humans that
IL-18 predicts the development of T2D (30) and that circulat-
ing levels of IL-18 are elevated in patients with T2D as compared
to non-diabetic controls (31–33). Due to the pro-inflammatory
nature of hyperinsulinemia, it is not surprising that correspond-
ing anti-inflammatory cytokines, IL-4, IL-10, IL-13, and TGF-β,
would also be upregulated in an effort to control the inflammation.
The case dolphin, however, died unexpectedly from anaphylactic
shock, and only one reference dolphin was used. While this is a
useful case study, larger scale investigations using more dolphins
with and without hyperinsulinemia and metabolic syndrome are
needed to further validate this study’s findings. Limitations to
such large-scale studies include opportunistic access to properly
processed fresh tissues from dolphins of known metabolic status.
Germinal center formation is a characteristic feature of T-
cell dependent, B-cell responses and may be an important site
of immune dysregulation in certain diseases. Development of
splenic germinal centers occurs over a period of days; the follicular
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FIGURE 4 | A germinal center, surrounded by aT-cell zone, in the spleen of a dolphin with hyperinsulinemia. Dolphin splenic tissue sections were
incubated with primary anti-Ki67, followed by anti-dolphin CD2, and nuclear staining using VECTASHIELD mounting medium with DAPI. Original magnification
20×.
FIGURE 5 | IL-6 and IL-8 expression in the spleen of a dolphin with hyperinsulinemia. Dolphin splenic tissue sections were incubated with primary
anti-porcine IL-6 or anti-dolphin IL-8, followed by anti-dolphin CD2, and nuclear staining using VECTASHIELD mounting medium with DAPI. Original magnification
20×.
FIGURE 6 |TGF-β expression in the spleen of a dolphin with hyperinsulinemia. Dolphin splenic tissue sections were incubated with primary anti-human
TGF-β, followed by nuclear staining using VECTASHIELD mounting medium with DAPI. Original magnification 20×.
dendritic cell network is filled with Ki67+ B cells by 7–9 days post-
immunization in mice (34). As the cytokine mRNA data suggested
the induction of cytokines known to play a role in isotype switch-
ing, we examined whether there was evidence of germinal center
formation in areas adjacent to the T-cell zone or periarteriolar lym-
phoid sheath in the spleen. In the present study, the splenic tissue
of the case dolphin with hyperinsulinemia was found to contain
numerous germinal centers containing Ki67+ cells. Interestingly,
this is similar to the observation of spontaneous germinal center
formation that has been described in strains of mice that develop
autoimmune type 1 diabetes (35).
Dolphins are emerging as a model for T2D due to some sim-
ilarities in metabolic perturbations to humans (17, 24, 26). This
study is the first to show that a dolphin with hyperinsulinemia and
metabolic syndrome displayed a similar pro-inflammatory state as
humans with hyperinsulinemia and T2D. Control tissues from a
number of healthy dolphins are needed to make any definitive
conclusions based on cytokine protein levels; this would be neces-
sary to determine a baseline expression of each cytokine. It is also
pertinent to look specifically at adipocytes and the adipokines they
secrete, as the adipose tissue is important in regulating metabo-
lism. Of the cytokines included herein, IL-6 has been shown to be
important in hyperinsulinemia in humans and alterations in levels
of IL-6 in the dolphin should be examined further. Soluble CD163
(sCD163) was shown to be associated with insulin resistance in
humans and may be a more reliable measure of T2D than TNF-α
(36); sCD163 secreted by macrophages should be examined fur-
ther in the dolphin as well. As used in this study, specific anti-ovine,
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FIGURE 7 | IL-1β, IL-4, and IL-10 expression in the spleen of a dolphin with hyperinsulinemia. Dolphin splenic tissue sections were incubated with primary
anti-ovine IL-1β, anti-bovine IL-4, or anti-bovine IL-10, followed by anti-dolphin CD2, and nuclear staining using VECTASHIELD mounting medium with DAPI.
Original magnification 20×.
FIGURE 8 | IFN-γ expression in the spleen of a dolphin with hyperinsulinemia. Dolphin splenic tissue sections were incubated with primary anti-bovine
IFN-γ, followed by nuclear staining using VECTASHIELD mounting medium with DAPI. Original magnification 20×.
-porcine, -bovine, and -human cytokine antibodies were shown to
cross-react with bottlenose dolphin tissues, as similarly described
for other cetaceans (37). Reagents for use in dolphins will need to
become more available for studying T2D and other diseases. The
availability of these reagents and dolphin-specific reagents that we
are developing in collaboration with Kingfisher Biotech, Inc., will
facilitate studies of immune modulation in managed bottlenose
dolphins.
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